Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Qi J, Li M, Wang L, Hu Y, Liu W, Long Z, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8(12):e943–55.

Article  PubMed  Google Scholar 

Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864–84.

Article  PubMed  Google Scholar 

Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–62.

Article  CAS  PubMed  Google Scholar 

Yang G, Yan H, Tang Y, Yuan F, Cao M, Ren Y, et al. Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: a comprehensive review. Chin J Cancer Res. 2023;35(3):266–82.

CAS  PubMed  PubMed Central  Google Scholar 

Xue JN, Wang YY, Wang YC, Zhang N, Zhang LH, Lu ZH, et al. Novel cellular therapies for hepatobiliary malignancies. Hepatobiliary Pancreat Dis Int. 2022;21(5):450–4.

Article  PubMed  Google Scholar 

Khan AA, Liu ZK, Xu X. Recent advances in immunotherapy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2021;20(6):511–20.

Article  CAS  PubMed  Google Scholar 

Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut. 2016;65(6):1035–41.

Article  CAS  PubMed  Google Scholar 

Kim SJ, Kim JM. Prediction models of hepatocellular carcinoma recurrence after liver transplantation: a comprehensive review. Clin Mol Hepatol. 2022;28(4):739–53.

Article  PubMed  PubMed Central  Google Scholar 

Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J, Liver. Transplantation 2023: Status Report, Current and Future Challenges. Clin Gastroenterol Hepatol. 2023;21(8):2150-66.

Wong RJ, Singal AK. Trends in Liver Disease etiology among adults awaiting liver transplantation in the United States, 2014–2019. JAMA Netw Open. 2020;3(2):e1920294.

Article  PubMed  Google Scholar 

Lu TF, Hua XW, Cui XL, Xia Q. Liver transplantation for hepatocellular carcinoma: recent advances in China. J Dig Dis. 2014;15(2):51–3.

Article  CAS  PubMed  Google Scholar 

Kim JM, Kim DG, Kim J, Lee K, Lee KW, Ryu JH, et al. Outcomes after liver transplantation in Korea: incidence and risk factors from Korean transplantation registry. Clin Mol Hepatol. 2021;27(3):451–62.

Article  PubMed  PubMed Central  Google Scholar 

He Z, She X, Liu Z, Gao X, Lu LU, Huang J, et al. Advances in post-operative prognostic models for hepatocellular carcinoma. J Zhejiang Univ Sci B. 2023;24(3):191–206.

Article  PubMed  Google Scholar 

Wang LY, Zheng SS. Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation. J Zhejiang Univ Sci B. 2018;19(7):497–504.

Article  PubMed  PubMed Central  Google Scholar 

Zhao JW, Shu X, Chen XX, Liu JX, Liu MQ, Ye J, et al. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram. Hepatobiliary Pancreat Dis Int. 2022;21(6):543–50.

Article  PubMed  Google Scholar 

Zhang FM, Wu HF, Shi HP, Yu Z, Zhuang CL. Sarcopenia and malignancies: epidemiology, clinical classification and implications. Ageing Res Rev. 2023;91:102057.

Article  PubMed  Google Scholar 

Tao J, Fang J, Chen L, Liang C, Chen B, Wang Z et al. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2023.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

Article  PubMed  Google Scholar 

Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;145:102839.

Article  CAS  PubMed  Google Scholar 

Xiao J, Mazurak VC, Olobatuyi TA, Caan BJ, Prado CM. Visceral adiposity and cancer survival: a review of imaging studies. Eur J Cancer Care (Engl). 2018;27(2):e12611.

Article  CAS  PubMed  Google Scholar 

Cheng E, Kirley J, Cespedes Feliciano EM, Caan BJ. Adiposity and cancer survival: a systematic review and meta-analysis. Cancer Causes Control. 2022;33(10):1219–46.

Article  PubMed  PubMed Central  Google Scholar 

Yu JJ, Shen F, Chen TH, Liang L, Han J, Xing H, et al. Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma. Br J Surg. 2019;106(3):276–85.

Article  CAS  PubMed  Google Scholar 

Gomez-Perez SL, Haus JM, Sheean P, Patel B, Mar W, Chaudhry V, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for Clinicians Using National Institutes of Health ImageJ. JPEN J Parenter Enter Nutr. 2016;40(3):308–18.

Article  Google Scholar 

Caan BJ, Cespedes Feliciano EM, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, et al. Association of Muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast Cancer. JAMA Oncol. 2018;4(6):798–804.

Article  PubMed  PubMed Central  Google Scholar 

McGovern J, Dolan RD, Horgan PG, Laird BJ, McMillan DC. Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(6):1408–17.

Article  PubMed  PubMed Central  Google Scholar 

Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–40.

Article  CAS  PubMed  Google Scholar 

Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5(1):201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, et al. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother. 2020;131:110680.

Article  CAS  PubMed  Google Scholar 

Berres ML, Papen S, Pauels K, Schmitz P, Zaldivar MM, Hellerbrand C, et al. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol. 2009;50(2):370–6.

Article  CAS  PubMed  Google Scholar 

Xiao XQ, Hassanein T, Li QF, Liu W, Zheng YH, Chen J. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker? Hepatobiliary Pancreat Dis Int. 2011;10(6):605–10.

Article  PubMed  Google Scholar 

Wang S, Chen S, Jin M, Hu M, Huang W, Jiang Z, et al. Diagnostic and prognostic value of serum chitinase 3-like protein 1 in hepatocellular carcinoma. J Clin Lab Anal. 2022;36(2):e24234.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu CB, Chen LL, Tian JJ, Su L, Wang C, Gai ZT, et al. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma a